Natural History of Nipah Virus in Hamsters: Strain, Route, and Sex-Associated Variability Characterized Using Large Datasets to Inform Pre-Clinical Study Design - Report - MDSpire
Advertisement
Natural History of Nipah Virus in Hamsters: Strain, Route, and Sex-Associated Variability Characterized Using Large Datasets to Inform Pre-Clinical Study Design
Clinical Report: Natural History of Nipah Virus in Syrian Hamsters
Overview
This extensive analysis of over 500 Syrian hamsters infected with Nipah virus (NiV) strains Malaysia and Bangladesh reveals significant differences in disease progression, lethality, and viral loads based on viral strain and inoculation route. The study provides a comprehensive dataset to optimize pre-clinical study design for medical countermeasure development.
Background
Nipah virus (NiV) is a highly pathogenic henipavirus causing severe respiratory and neurological disease in humans, with two main strains: Malaysia (NiV-M) and Bangladesh (NiV-B). Human outbreaks are sporadic and often fatal, with no FDA-approved treatments currently available. Syrian hamsters serve as a valuable animal model, replicating the full spectrum of human disease without requiring immunosuppression. However, variability in disease presentation depending on strain, dose, and inoculation route complicates study design and interpretation.
Data Highlights
Parameter
NiV-M (Malaysia)
NiV-B (Bangladesh)
Number of Hamsters Infected
Data included in 522 total NiV-infected animals
Data included in 522 total NiV-infected animals
Inoculation Routes
Intranasal (IN), Intraperitoneal (IP)
Intranasal (IN), Intraperitoneal (IP)
Dose Range (TCID50)
10^2 to 10^7
10^2 to 10^7
Clinical Assessment
Daily scoring, weight, temperature monitoring
Daily scoring, weight, temperature monitoring
Study Duration
Up to 28 days post-infection
Up to 28 days post-infection
Key Findings
NiV strain and inoculation route significantly influence clinical course and lethality in Syrian hamsters.
Intranasal inoculation tends to mimic respiratory disease progression more closely than intraperitoneal administration.
NiV-Bangladesh strain generally causes more severe disease and higher lethality compared to NiV-Malaysia in this model.
Large group sizes are necessary to account for variability in disease presentation and outcome.
Individual-level data analysis enhances understanding of disease progression and supports robust pre-clinical study design.
Syrian hamsters recapitulate key respiratory and neurological features of human NiV infection without immunosuppression.
Clinical Implications
These findings underscore the importance of selecting appropriate NiV strains and inoculation routes when designing pre-clinical studies to evaluate medical countermeasures. The large aggregated dataset supports the use of Syrian hamsters as a reliable model to predict human disease progression and optimize timing and endpoints for therapeutic interventions.
Conclusion
This comprehensive natural history analysis of NiV infection in Syrian hamsters provides critical insights into strain- and route-dependent disease variability, establishing a robust framework to guide future pre-clinical research and accelerate medical countermeasure development.
References
CDC/US Army/2018-2025 -- Nipah Virus Natural History in Syrian Hamsters
